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Introduction {#sec1}
============

The frequency of somatic mutations and clonal hematopoiesis, known risk factors of hematological cancer, increase dramatically with aging ([@bib15]; [@bib30]). Numerous mouse studies have shown that hematopoietic stem cells (HSCs) lose their repopulation capacity while increasing their quiescence and frequency with aging ([@bib14]; [@bib26]). Aging also favors myeloid, megakaryocytic, and erythroid over lymphoid lineages ([@bib8]; [@bib27]), which has been linked to the influence of intrinsic ([@bib2]; [@bib6]; [@bib26]) and microenvironmental factors ([@bib11]; [@bib19]; [@bib34]). In mouse models, bone marrow (BM) microenvironmental populations that have been reported to be essential for hematopoietic regulation include osteoblasts, endothelial cells, bone marrow stromal cells (BMSCs), and adipocytes ([@bib1]; [@bib10]; [@bib9]; [@bib36]). Aging-associated changes in these populations result in changes in BM architecture, including vascular remodeling ([@bib21]; [@bib28]), decreases in trabecular area, and increases in adipocyte area ([@bib29]). In contrast, BMSC frequency has been reported to remain stable in mouse BM with aging ([@bib21]; [@bib28]).

In humans, aging studies are limited by sample availability of benign BM. Furthermore, many studies compared older adult BM with pediatric groups obscuring possible differences between middle-aged and older adults; a key age range when the incidence of myeloid neoplasia markedly increases. Samples from oncologic patients (staging marrows) are often included that may not reflect normal individuals ([@bib23]). Functional studies have found epigenetic and genetic changes of human aged HSCs ([@bib24]; [@bib27]; [@bib31]). However, these reports on the effect of aging on myeloid-lymphoid lineage skewing are few and showed contradictory findings. Although, there is an evident decline of lymphoid lineages ([@bib18]; [@bib24]; [@bib27]), changes within the myeloid lineage with age are less clear, as a decline or no effect has been reported ([@bib18]; [@bib24]). While older individuals show an increase in BM adipocytes ([@bib17]), the reports on BMSCs are not consistent ([@bib20]; [@bib37]).

To date, it remains unknown whether age-related changes occur in human CD34+ hematopoietic stem and progenitor cells (HSPCs) and their myeloid progeny in the BM microenvironment. Here, we report a systematic comparison of the frequency and location of maturing myeloid and CD34+ HSPCs with respect to the marrow microenvironment composed of adipocytes, vessels, and BMSCs of hematologically normal BM from individuals aged from 50 to 92 years.

Results and Discussion {#sec2}
======================

Aging Alters BM Architecture by Increasing Adipocytes, CD34+ HSPCs, and Maturing Myeloid Cells {#sec2.1}
----------------------------------------------------------------------------------------------

Two BM regions were defined to quantify and compare the different BM cell populations between middle-aged (50--64 years) and older adults (65--92 years). These regions were non-bone area, which excludes artifacts and trabeculae; and hematopoietic area (parenchyma), corresponding to the non-bone/non-adipocytic region, which is recognized by hematoxylin stain ([Figure 1](#fig1){ref-type="fig"}A). Non-bone area was used to quantify adipocytes and the hematopoietic area was used to quantify the rest of the BM cell populations. Cell markers were selected according to their specificity and sensitivity. Myeloperoxidase (MPO) was used for maturing myeloid cells ([@bib33]); CD34 was selected for HSPC detection, as it identifies all HSPCs, including HSCs and myeloid and lymphoid progenitors ([@bib4]). Adipocytes were identified using perilipin ([@bib5]); and, for BMSCs, low-affinity nerve growth factor receptor (NGFR) was used. NGFR was chosen due to strong *in vitro* and *in situ* evidence that this marker highlights BMSCs ([@bib25]; [@bib32]). Systematic scoring and image analysis of middle-aged and older adult BM showed a statistically significant decrease in hematopoietic area ([Figure 1](#fig1){ref-type="fig"}B) and an increase in adipocytic content in older adult BM ([Figures 1](#fig1){ref-type="fig"}C and 1D). Both age groups have the same density of NGFR+ BMSCs ([Figures 1](#fig1){ref-type="fig"}C and 1E). Middle-aged and older adult BM showed no difference on the percentage of CD34+ HSPCs, measured as the percentage of CD34+ cells over total nuclei within the hematopoietic area (p = 0.14, data not shown). However, a strong positive correlation was found between CD34+ HSPCs and age ([Figures 1](#fig1){ref-type="fig"}C and 1F). Moreover, an increase in maturing myeloid cells, was observed in the hematopoietic area of BM of older adults ([Figures 1](#fig1){ref-type="fig"}C and 1G). To determine if the increase in maturing myeloid cells in the BM of older adults, is also seen in peripheral blood, peripheral blood counts from both groups were compared. We found an increase in total myeloid cells and a decrease in lymphoid cells in the older adult group ([Table 1](#tbl1){ref-type="table"}). Our findings confirm previous studies that reported an increase in HSPCs ([@bib18]; [@bib24]; [@bib27]). However, in contrast to our results, these studies did not find an increase in myeloid cells. While previous reports used flow cytometry to detect committed progenitors, our study measured maturing myeloid cells *in situ* by IHC.Figure 1Aged Human BM Shows an Increased Density of Adipocytes, CD34+ HSPCs, and Maturing Myeloid Cells(A) Representative images of an H&E stain of a middle-aged adult BM (total bone marrow area) and quantification of non-bone and hematopoietic area. Non-bone area (yellow area) excluding trabeculae (asterisk). Hematopoietic area (red area) excluding trabeculae (asterisk) and adipocytes (arrow). Scale bar, 100 μm. IHC staining, DAB; counterstain, hematoxylin. 20× magnification.(B) Percentage of BM hematopoietic area in both age groups: 50--64 years (n = 7) versus 65--92 years (n = 5), p = 0.03.(C) Representative IHC images (original) of adipocytes, NGFR+ BMSCs, CD34+ HSPCs, and maturing myeloid cells in BM biopsies from hematologically healthy patients aged 50--64 and 65--92 years. Each image is accompanied by its objects' identification outline image produced by CellProfiler (Image Analysis). Scale bar, 200 μm.(D) Adipocyte density in patients aged 50--64 years (n = 7) and 65--92 years (n = 5). p = 0.03.(E) NGFR+ BMSC density: 50--64 years (n = 7) versus 65--92 years (n = 7), p = 0.14.(F) Association between CD34+ HSPCs and age. Pearson correlation test, r = 0.71, n = 10.(G) Maturing myeloid cell density: 50--64 (n = 7) and 65--92 years (n = 5), p = 0.01.Table 1Peripheral Blood Parameters from Hematologically Healthy Patients Aged 50--92 YearsAge GroupsLeukocytes (10^3^/μL)Myeloid Cells (10^3^/μL)Neutrophils (10^3^/μL)Monocytes (10^3^/μL)Lymphocytes (10^3^/μL)Erythrocytes (10^3^/μL)Hematocrit (%)Platelets (10^3^/μL)50--64 years (n = 28)7.15 ± .594.92 ± .394.21 ± 0.380.52 ± 0.042.26 ± 0.144.62 ± 0.0840.67 ± 0.74254.1 ± 11.0965--92 years (n = 30)8.36 ± .736.54 ± .555.70 ± 0.530.64 ± 0.041.78 ± 0.134.55 ± 0.0941.16 ± 0.80274.6 ± 15.37p values0.210.020.020.040.010.580.660.28

CD34+ HSPCs Are Immediately Adjacent to Adipocytes Maintaining Perivascular Location in Middle-Aged and Older Adult Human BM {#sec2.2}
----------------------------------------------------------------------------------------------------------------------------

Given the increased number of CD34+ HSPCs and adipocytes in the BM of older adults, we determined if there was an association between these two populations. We confirmed a positive correlation between the density of adipocytes and CD34+ HSPCs in samples from both groups ([Figure 2](#fig2){ref-type="fig"}A). Furthermore, we observed CD34+ HSPCs located immediately adjacent to adipocytes ([Figure 2](#fig2){ref-type="fig"}B). Interestingly, we found a statistically significant increase in the percentage of CD34+ HSPCs immediately adjacent to adipocytes in the older adult group ([Figures 2](#fig2){ref-type="fig"}B and 2C). Given the increased adipocyte content in the BM of older adults, we also tested whether a single adipocyte could make contact with more than one CD34+ HSPC. Interestingly, we found a higher number of adipocytes immediately adjacent to more than one CD34+ HSPC in older individuals ([Figure 2](#fig2){ref-type="fig"}D).Figure 2Human Aging Is Associated with Increased Adjacency between CD34+ HSPCs and Adipocytes(A) Positive correlation between adipocytes and CD34+ HSPCs. Pearson correlation test, r = 0.56, n = 10.(B) Representative images of CD34+ HSPCs spatially associated with adipocytes in BM biopsies from hematologically healthy patients aged 50--64 and 65--92 years. From left to right, CD34+ HSPCs IHC image, CD34+ objects' detection image and digitalized image showing cells not adjacent (in blue) and immediately adjacent to adipocytes (in green and red). Scale bar, 200 μm.(C) Bar graph showing number of CD34+ HSPCs not adjacent and immediately adjacent to adipocytes: 50--64 years (n = 6) versus 65--92 years (n = 4), two-way ANOVA, p = 0.01, unpaired t test, immediately adjacent to adipocytes, p = 0.01.(D) Bar graph showing number of adipocytes immediately adjacent to 1 or \>1 CD34+ HSPCs: 50--64 years (n = 6) versus 65--92 years (n = 4), two-way ANOVA p = 0.052, unpaired t test, \>1 in both age groups, p = 0.05.(E) Bar graph showing CD34+ HSPC distance to vessels. Graph representing percentage of CD34+ HSPCs at a distance of 0--10, 10--20, and \>20 μm from vessels: 50--64 years (n = 3) versus 65--92 years (n = 3), two-way ANOVA p = 0.27.(F) Representative IMC images showing an overlay of CD34+ HSPCs (red channel), NGFR+ BMSCs (green channel), and adipocytes (blue channel) in BM biopsies from hematologically healthy patients aged 50--64 (n = 2) and 65--92 years (n = 3). Scale bar, 100 μm. Adjacency between CD34+ HSPCs, NGFR+ BMSCs, and adipocytes are indicated by white arrows.

Functional studies using mouse models have shown that BMSCs are key components of the hematopoietic stem cell niche ([@bib10]); and in humans it has been reported that more than 80% of CD34+ HSPCs are in close contact to NGFR+ BMSCs in perivascular areas ([@bib13]). Therefore, we assessed whether the increased association of CD34+ HSPCs to adipocytes in older adults had an impact on their perivascular distribution and contact with NGFR+ BMSCs. We found that CD34+ HSPCs in human BM, from both groups, are located in perivascular areas, with \>80% of HSPCs located \<10 μm from the closest blood vessel, with no differences between age groups ([Figure 2](#fig2){ref-type="fig"}E). Using imaging mass cytometry (IMC) technology, we found that, in all samples analyzed from both age groups, CD34+ HSPCs remained in close contact to NGFR+ BMSCs ([Figure 2](#fig2){ref-type="fig"}F).

Aging Increases Maturing Myeloid Cell Density Surrounding Adipocytes {#sec2.3}
--------------------------------------------------------------------

We next assessed whether there was an association between the density of maturing myeloid cells and adipocytes and found only a weak positive association ([Figure 3](#fig3){ref-type="fig"}A). However, given that both cell populations are increased with aging, we studied whether maturing myeloid cells preferentially locate closer to adipocytes. We analyzed maturing myeloid cell density in the immediate hematopoietic area surrounding adipocytes (within one cell distance from adipocyte membrane) and in the parenchyma (at least two-cell distance from adipocyte membrane) ([Figure 3](#fig3){ref-type="fig"}B, middle panel). Using image analysis software, we quantified maturing myeloid cell density in the above-mentioned areas of BM from middle-aged and older adult groups ([Figure 3](#fig3){ref-type="fig"}B, lower panel). Maturing myeloid cells distribute equally in both hematopoietic areas in both age groups ([Figure 3](#fig3){ref-type="fig"}C). However, we found a higher density of maturing myeloid cells surrounding adipocytes in the older adult group in comparison with the middle-aged group ([Figure 3](#fig3){ref-type="fig"}C). Such difference was not observed when comparing parenchyma areas of both age groups, suggesting that increases in maturing myeloid cell density associated to aging occur in the hematopoietic areas close to adipocytes. Our results support recent findings suggesting that adipocytes are the niche cells for myelopoiesis ([@bib5]).Figure 3Human Aging Increases Maturing Myeloid Cell Density in Hematopoietic Areas Surrounding Adipocytes(A) Weak correlation between adipocytes and maturing myeloid cell density. Pearson correlation test, r = 0.31, n = 11.(B) Representative IHC images of maturing myeloid cells (MPO) (original) in BM biopsies from hematologically healthy patients aged 50--64 and 65--92 years (upper panel). Adipocyte area (A) and parenchyma (P) delimitation for image analysis quantification (middle panel). Image analysis of A and P, showing positive (yellow to red) and negative (blue) areas (lower panel). Scale bar, 200 μm.(C) Bar graph showing the density of maturing myeloid cells in adipocyte area and parenchyma of the 50--64-year (n = 7) and 65--92-year (n = 5) groups. Two-way ANOVA, p = 0.002, unpaired t test, adipocyte area, p = 0.007.(D) Representative IMC images showing an overlay of maturing myeloid cells (red channel), CD34+ HSPCs (green channel), and adipocytes (blue channel) in BM biopsies from hematologically healthy patients aged 50--64 years (n = 2) and 65--92 years (n = 3). Scale bar, 100 μm. Adjacency between maturing myeloid cells, CD34+ HSPCs, and adipocytes are indicated by white arrows.(E) Diagram showing the percentage of CD34+ HSPCs adjacent to maturing myeloid cells out of percentage of CD34+ HSPCs adjacent to adipocytes in both age groups. Percentage of CD34+ HSPCs adjacent to adipocytes was calculated from IHC analysis and the percentage of CD34+ HSPCs adjacent to both adipocytes and maturing myeloid cells was calculated from IMC analysis.(F) Proposed model of physiological aging-related changes in human BM spatial organization. Increasing marrow adiposity correlates with an increased CD34+ HSPC and maturing myeloid density and adjacency with adipocytes, while contact with MSCs and perivascular localization remains unchanged across age groups.

Based on the increases that we found in CD34+ HSPCs and maturing myeloid cells surrounding adipocytes with aging, we next assessed whether CD34+ HSPCs adjacent to adipocytes were also close to maturing myeloid cells. Using IMC technology, we identified CD34+ HSPCs that were both adjacent to adipocytes and maturing myeloid cells in BM samples from both age groups ([Figure 3](#fig3){ref-type="fig"}D). Consequently, we calculated the percentage of CD34+ HSPCs adjacent to adipocytes that were also adjacent to maturing myeloid cells in both age groups (50--64 years, n = 2; 65--92 years, n = 3). In all samples analyzed, \>70% of CD34+ HSPCs adjacent to adipocytes were adjacent to maturing myeloid cells ([Figure 3](#fig3){ref-type="fig"}E). The increased association of CD34+ HSPCs to adipocytes with aging and the spatial association of myeloid cells with adipocytes suggests that adipocytes may be favoring myeloid differentiation ([Figure 3](#fig3){ref-type="fig"}E).

Our study refines the location of CD34+ HSPCs in humans across the spectrum of middle-aged to elderly BM. We showed that CD34+ HSPCs are located in a perivascular area and in close contact to NGFR+ BMSCs across all age groups, but there was increased association with adipocytes in older age groups. To our knowledge, this is the first report that locates CD34+ HSPCs immediately adjacent to adipocytes and highlights that aging correlates with changes in the location of CD34+ HSPCs in humans. This result highlights the importance of human studies, since adipocytes are underrepresented in mouse models ([@bib12]), which tend to rely on nearly adipocyte-free mouse femurs. While some previous studies suggested a negative role for adipocytes as regulators of the hematopoietic microenvironment ([@bib22]), there is now accumulating evidence pointing to adipocytes as positive regulators by promoting the regeneration of HSCs ([@bib36]) and playing an important role in HSPC mobilization ([@bib35]). Our findings refine a periadipocytic/perivascular location of CD34+ HSPCs in humans that increases with aging ([Figure 3](#fig3){ref-type="fig"}F). The increased mature myeloid output that correlates with these findings raises the idea that these age-related changes in the interplay of HSPCs to their microenvironment may influence myeloid skewing and the attendant risk of myeloid malignancy.

Experimental Procedures {#sec3}
=======================

BM Samples {#sec3.1}
----------

Femoral heads were collected from non-hematological, non-oncological patients aged 50 to 92 years (n = 58), undergoing hip replacement surgery at the Traumatology and Orthopedics Hospital Lomas Verdes (IMSS), Mexico. Ethical approval was obtained from IMSS institutional review board (R-2012-785-092). Clinical data from patients were retrieved.

Histology and Immunohistochemistry {#sec3.2}
----------------------------------

Femoral heads were fixed in 10% formaldehyde. BM pieces of 2--3 cm in length were cut from the femoral neck and decalcified in 12% EDTA/PBS (pH 8; Sigma-Aldrich) solution for 10 days, then dehydrated and paraffin-embedded (Paraplast, Leica Biosystems) using a Multifunctional Tissue Processor KOS (Milestone). All samples were evaluated by two independent hematopathologists. A total of 75% of samples were excluded due to identified dysplasia of any of the hematopoietic lineages or lack of hematopoietic tissue present. IHC staining was performed as described previously ([@bib13]). Antigen retrieval was performed using citrate buffer solution (pH 6; Sigma-Aldrich) with 0.05% Tween 20 (Sigma-Aldrich) at 110°C for 5 min using KOS (Milestone). Primary antibodies used were the following: MPO, rabbit, 1:250 (polyclonal/Abcam); Perilipin, rabbit, 1:1,000 (polyclonal/Abcam); NGFR, rabbit, 1:50 (clone EP1039Y/Biogenex), and CD34, rabbit, 1:5,000 (clone EP373Y/Genetex). Secondary antibody kit used was anti-rabbit (Vector Laboratories).

Image Analysis {#sec3.3}
--------------

Slides were scanned using Aperio CS2 (Leica Biosystems). Three 20× field images per sample were analyzed. For NGFR and adipocytes previous published pipelines were used ([@bib3]; [@bib16]). For CD34 and MPO, pipelines were created and are available in <https://github.com/Alicia-AguilarN/Cell-Profiler-pipelines>.  For CD34+ HSPC and adipocyte spatial association analysis, a pipeline with neighbor analysis module was created, which is also available in <https://github.com/Alicia-AguilarN/Cell-Profiler-pipelines>. ImageJ software was used to measure distance between CD34+ HSPCs and vessels and for manual quantification of CD34+ HSPCs adjacent to both adipocytes and NGFR+ BMSCs and maturing myeloid cells and adipocytes. For quantification of positive area of maturing myeloid cells surrounding adipocytes and parenchyma, positive pixel count algorithm was used in Image Scope software (Leica Biosystems).

IMC {#sec3.4}
---

IMC staining and ablation was carried out as reported previously ([@bib7]). Antibodies used for IMC staining were CD34-158Gd (1:100), Perilipin-142Nd (1:100), NGFR-160Gd (1:50), and MPO-146Nd (1:2,000). Overlaid images were obtained using Wolfram Mathematica v.10.3 software (Fluidigm). Images were contrast-enhanced by Adobe photoshop only for visualization purposes.

Statistics {#sec3.5}
----------

Statistics were performed using GraphPad Prism version 5.01 for Windows (GraphPad software, La Jolla, CA, USA, [www.graphpad.com](http://www.graphpad.com){#intref0020}). For two-group comparisons, unpaired t test was used. For multiple comparisons, two-way ANOVA followed by Bonferroni post-test were performed. Results are presented as the mean ± SEM. Correlation analysis were performed using Pearson correlation test.
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